PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsPain
MeSH D010146 - pain
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012677:Sensation
0 Companies
0 Drugs
Success rate
D009461:Neurologic manifestations
$
Success rate
D010146: 
Pain
D017288:Pain threshold
0 Companies
0 Drugs
Success rate
D018771:Arthralgia
0 Companies
0 Drugs
Success rate
D056844:Renal colic
0 Companies
0 Drugs
Success rate
D000072716:Cancer pain
0 Companies
0 Drugs
Success rate
D000073818:Procedural pain
0 Companies
0 Drugs
Success rate
D001416:Back pain
$
Success rate
D002637:Chest pain
0 Companies
0 Drugs
Success rate
D004433:Earache
0 Companies
0 Drugs
Success rate
D005157:Facial pain
$
Success rate
D005926:Glossalgia
0 Companies
0 Drugs
Success rate
D006261:Headache
D009437:Neuralgia
$
Success rate
D010148:Intractable pain
$
Success rate
D010149:Postoperative pain
D015746:Abdominal pain
$
Success rate
D017699:Pelvic pain
0 Companies
0 Drugs
Success rate
D019547:Neck pain
$
Success rate
D021501:Flank pain
0 Companies
0 Drugs
Success rate
D037061:Metatarsalgia
0 Companies
0 Drugs
Success rate
D048949:Labor pain
0 Companies
0 Drugs
Success rate
D053591:Referred pain
0 Companies
0 Drugs
Success rate
D058447:Eye pain
$
Success rate
D059226:Nociceptive pain
0 Companies
0 Drugs
Success rate
D059350:Chronic pain
$
Success rate
D059352:Musculoskeletal pain
$
Success rate
D059373:Mastodynia
0 Companies
0 Drugs
Success rate
D059390:Breakthrough pain
0 Companies
0 Drugs
Success rate
D059787:Acute pain
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
90%
95/106
Phase 2
70%
114/162
Phase 3
78%
174/224
Approved: 71Overall Success rate: 49%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
4
5
6
...
21
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use